Adverum Biotechnologies (LTS:0HA3) Pre-Tax Income : $-113.99 Mil (TTM As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Adverum Biotechnologies Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Adverum Biotechnologies's pretax income for the three months ended in Mar. 2024 was $-24.79 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was $-113.99 Mil. Adverum Biotechnologies's pretax margin was %.

During the past 12 years, Adverum Biotechnologies's highest Pretax Margin was -1940.53%. The lowest was -25794.40%. And the median was -3862.90%.

Adverum Biotechnologies Pre-Tax Income Historical Data

The historical data trend for Adverum Biotechnologies's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adverum Biotechnologies Pre-Tax Income Chart

Adverum Biotechnologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Pre-Tax Income

Get a 7-Day Free Trial

-64.49

-116.39

-145.54

-154.46

-118.24

Adverum Biotechnologies Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Pre-Tax Income	Get a 7-Day Free Trial															-29.04	-31.49	-32.87	-24.85	-24.79

Competitive Comparison of Adverum Biotechnologies's Pre-Tax Income

For the Biotechnology subindustry, Adverum Biotechnologies's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Adverum Biotechnologies's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Adverum Biotechnologies's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Adverum Biotechnologies's Pre-Tax Income falls into.

Adverum Biotechnologies Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Adverum Biotechnologies's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-123.991	+	5.748	+	0	+	0	+	0
	=	-118.24

Adverum Biotechnologies's Pretax Income for the quarter that ended in Mar. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-26.839	+	2.052	+	0	+	0	+	0
	=	-24.79

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-113.99 Mil.

Adverum Biotechnologies (LTS:0HA3) Pre-Tax Income Explanation

Adverum Biotechnologies's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-24.787	/	0
	=	%

During the past 12 years, Adverum Biotechnologies's highest Pretax Margin was -1940.53%. The lowest was -25794.40%. And the median was -3862.90%.

Adverum Biotechnologies Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Adverum Biotechnologies's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Adverum Biotechnologies (LTS:0HA3) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adverum Biotechnologies Inc (LTS:0HA3) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

ADVM:USA

Address

100 Cardinal Way, Redwood CIty, CA, USA, 94063

Website

https://www.adverum.com

Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company primarily generates revenue through license, research and collaboration arrangements with its strategic partners. Its lead product candidate is ADVM-022 which is a single, in-office intravitreal (IVT) injection gene therapy designed to deliver long-term durable levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with frequent anti-vascular endothelial growth factor (VEGF) injections. It has one segment developing and commercializing gene therapeutics.

Adverum Biotechnologies (LTS:0HA3) Headlines

No Headlines